Intracranial Pressure Monitoring Devices

Intracranial Pressure Monitoring Devices Market Outlook

The global intracranial pressure monitoring devices market is poised to grow significantly, with an estimated market size of USD 1.2 billion in 2023 and a projected compounded annual growth rate (CAGR) of approximately 6.1% from 2025 to 2035. This growth can be attributed to the rising prevalence of neurological disorders, increasing incidence of traumatic brain injuries, and advancements in medical technology. Additionally, the growing awareness regarding the importance of monitoring intracranial pressure in critical care settings is driving demand for these monitoring devices. The market is also benefiting from investments in healthcare infrastructure and increased funding for research in neurocritical care. Moreover, the recovery from the COVID-19 pandemic has led to an uptick in hospital admissions, further propelling the growth of this market.

Growth Factor of the Market

The growth of the intracranial pressure monitoring devices market is significantly influenced by several key factors. First and foremost, the rising incidence of neurological disorders, such as stroke, traumatic brain injuries, and brain tumors, has increased the need for effective monitoring solutions. This demand is further facilitated by technological advancements that enhance device accuracy and ease of use. The shift towards minimally invasive procedures is also a crucial factor, as non-invasive monitoring techniques are gaining traction, appealing to both healthcare providers and patients. Moreover, an aging population is contributing to higher healthcare needs, further necessitating the use of advanced monitoring devices. In addition, ongoing research and development activities aimed at improving device design and functionality are expected to augment market growth over the forecast period.

Key Highlights of the Market

• The market is witnessing a surge in demand for non-invasive ICP monitoring devices due to patient comfort and reduced complication risks.
• Technological innovations, particularly in micro-electromechanical systems (MEMS), are enhancing device performance and reliability.
• The application of ICP monitoring in emergency departments is increasing, driven by the rise in traumatic brain injuries.
• Hospitals are the primary end-users, accounting for a significant share of the market due to the high volume of neurological cases.
• North America is expected to dominate the market, attributed to advanced healthcare infrastructure and higher adoption rates of innovative monitoring technologies.

By Product Type

Invasive ICP Monitoring Devices:

Invasive intracranial pressure monitoring devices are designed to provide accurate and real-time measurements of intracranial pressure through direct access to the cerebrospinal fluid (CSF). These devices are typically used in critically ill patients who require continuous monitoring due to severe neurological conditions. Invasive devices, such as ventricular catheters, offer precise data that are crucial for therapeutic interventions. However, their use carries risks of infection and other complications, which has led to a growing interest in the development of safer and more efficient alternatives. Nonetheless, the reliability and accuracy of invasive monitoring devices continue to make them a staple in neurocritical care settings, sustaining their demand in the market.

Non-Invasive ICP Monitoring Devices:

Non-invasive intracranial pressure monitoring devices are increasingly gaining popularity due to their ability to assess ICP without the need for surgical interventions. These devices utilize advanced technologies such as transcranial Doppler ultrasonography and near-infrared spectroscopy to provide estimates of intracranial pressure. The advantage of non-invasive methods lies in their lower complication rates, making them suitable for a wider patient demographic, including those who may not tolerate invasive procedures. As healthcare providers emphasize patient-centered care, the market for non-invasive ICP monitoring devices is expected to expand significantly, driven by technological advancements that improve accuracy and ease of use.

By Application

Traumatic Brain Injury:

Traumatic brain injury (TBI) is one of the leading applications for intracranial pressure monitoring devices. The increasing incidence of TBIs, particularly from road accidents, falls, and sports-related injuries, necessitates effective monitoring to prevent secondary brain damage. Continuous ICP monitoring is crucial in managing patients with TBI, as it helps guide therapeutic interventions and aids in decision-making for surgical interventions. The rising awareness among healthcare professionals regarding the importance of ICP monitoring in TBI management is expected to drive the market for these devices within this specific application segment.

Stroke:

Stroke is another significant application area for intracranial pressure monitoring devices, as timely and accurate monitoring of ICP is essential in managing this condition. Patients who experience strokes often face complications related to elevated intracranial pressure, making ongoing monitoring critical for improving outcomes. The growing prevalence of stroke, driven by factors such as an aging population and lifestyle-related health issues, is expected to bolster the demand for ICP monitoring devices. Additionally, advancements in monitoring technologies that allow for rapid assessment and intervention will further enhance the role of these devices in stroke management.

Intracerebral Hemorrhage:

Intracerebral hemorrhage (ICH) is a condition characterized by bleeding within the brain tissue, which can lead to increased intracranial pressure. Monitoring ICP in patients with ICH is crucial for early detection of complications and for guiding treatment decisions. The rising incidence of ICH, driven by factors such as hypertension and anticoagulant use, is a driving force for the ICP monitoring devices market. As healthcare providers seek to mitigate the risks associated with ICH, the demand for effective monitoring solutions is anticipated to increase, further emphasizing the importance of these devices in the clinical setting.

Meningitis:

Meningitis, an inflammation of the protective membranes covering the brain and spinal cord, can result in elevated intracranial pressure, making ICP monitoring vital for patient management. The increasing incidence of bacterial and viral meningitis, particularly in vulnerable populations such as infants and the elderly, is expected to drive demand in this application segment. Effective monitoring allows for timely therapeutic interventions, reducing potential complications. The growing awareness of the importance of ICP monitoring in managing patients with meningitis is likely to sustain growth in this area of the market.

Others:

The "Others" category encompasses a range of conditions that may necessitate intracranial pressure monitoring, including brain tumors, hydrocephalus, and post-operative monitoring. The diverse applications in this segment illustrate the versatility of ICP monitoring devices in addressing various medical needs. As healthcare providers continue to prioritize patient safety and outcomes, the demand for ICP monitoring in these additional applications is expected to rise. Ongoing research and advancements in monitoring technologies will further enhance the potential for these devices to be utilized across a broader spectrum of neurological conditions.

By User

Hospitals:

Hospitals are the primary end-users of intracranial pressure monitoring devices, accounting for the largest market share. High-pressure areas within hospitals, such as neurocritical care units and emergency departments, heavily rely on ICP monitoring to manage patients with severe neurological conditions. The presence of trained healthcare professionals and advanced medical infrastructure in hospitals supports the effective use of these devices. Additionally, hospitals often have access to the latest technologies and can implement them more readily for monitoring patients at risk of elevated ICP, driving sustained demand for these devices in this segment.

Clinics:

Clinics, particularly specialized neuro clinics, are becoming increasingly significant end-users of intracranial pressure monitoring devices. These outpatient settings often handle follow-up care for patients with neurological conditions, including those recovering from traumatic brain injuries or surgeries. As clinics adopt advanced monitoring technologies, they can provide better patient care through timely assessments and interventions. The trend towards outpatient care and the increasing focus on preventive medicine are expected to bolster the demand for ICP monitoring devices in clinical settings.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) are an emerging segment in the end-user category for intracranial pressure monitoring devices. These centers provide a range of surgical procedures on an outpatient basis, and as more complex procedures are performed in ASCs, the need for effective monitoring solutions is growing. The focus on minimally invasive techniques and the ability to monitor patients post-operatively for potential complications are driving the adoption of ICP monitoring devices in these settings. As ASCs continue to expand their capabilities, the demand for reliable intracranial pressure monitoring will likely increase.

Others:

The "Others" segment includes various healthcare facilities and settings that may utilize intracranial pressure monitoring devices, such as rehabilitation centers and research institutions. Although the market share from this segment may be smaller compared to hospitals and clinics, it represents a unique opportunity for device manufacturers to expand their reach. Research institutions may employ ICP monitoring in clinical studies aimed at developing new treatments for neurological conditions, while rehabilitation facilities may utilize these devices as part of their patient management protocols. The diversification of end-users will contribute to the overall growth of the intracranial pressure monitoring devices market.

By Technology

Micro-Electro-Mechanical Systems (MEMS):

Micro-electromechanical systems (MEMS) technology is revolutionizing the intracranial pressure monitoring devices market by offering miniaturized solutions that enhance the accuracy and reliability of measurements. MEMS-based ICP monitors are designed to integrate seamlessly with other medical devices, making them ideal for use in various clinical settings. Their compact size allows for easier placement and improved patient comfort, as they can be implemented with minimal invasiveness. Furthermore, ongoing advancements in MEMS technology are expected to drive innovation, propelling the growth of this segment as healthcare providers increasingly adopt these advanced monitoring solutions.

Fiber Optic Sensors:

Fiber optic sensors represent a cutting-edge technology in the field of intracranial pressure monitoring, offering tremendous advantages in terms of sensitivity and precision. These sensors can measure pressure changes accurately while being minimally invasive, enhancing patient safety and comfort. The application of fiber optic sensors in ICP monitoring allows for real-time data collection, which is critical in managing conditions such as traumatic brain injuries and intracerebral hemorrhages. As the demand for accurate and reliable monitoring solutions continues to rise, fiber optic technology is expected to play an increasingly important role in the growth of the market.

Strain Gauge Sensors:

Strain gauge sensors are widely used in intracranial pressure monitoring devices to accurately detect changes in pressure within the cranial cavity. These sensors respond to the deformation caused by pressure fluctuations, allowing for real-time monitoring of ICP levels. While strain gauge sensors are effective, they may require more invasive techniques for placement, which can increase the risk of complications compared to non-invasive alternatives. Nevertheless, their reliability and established use in clinical settings continue to drive demand in the market, particularly for patients requiring continuous monitoring in critical situations.

Others:

The "Others" category includes a range of emerging technologies and methodologies utilized in intracranial pressure monitoring, such as acoustic and electrical impedance techniques. These alternative technologies aim to provide additional options for clinicians, especially in scenarios where traditional methods may not be suitable. Ongoing research into innovative monitoring solutions is expected to expand the scope of this segment, offering healthcare providers new ways to manage intracranial pressure effectively. As the market evolves, the integration of various technologies will likely enhance patient care and improve overall outcomes in neurology.

By Mechanical Systems

External Ventricular Drains (EVD):

External ventricular drains (EVD) are a common mechanical system used in the management of intracranial pressure, allowing for both monitoring and drainage of cerebrospinal fluid. EVDs are particularly beneficial in cases of hydrocephalus or brain injury, as they provide a reliable means of reducing elevated ICP while simultaneously offering accurate pressure readings. The dual functionality of EVDs makes them a preferred choice in neurocritical care settings. As advancements in EVD technology continue, including improvements in materials and ease of use, their adoption is expected to grow, contributing to the overall market expansion.

Intraparenchymal Monitors:

Intraparenchymal monitors are designed to measure intracranial pressure directly within the brain tissue, providing accurate and localized pressure readings. These mechanical systems offer high-resolution data and are often used in conjunction with EVDs for comprehensive patient monitoring. The ability to assess ICP in real-time allows healthcare providers to make informed decisions regarding treatment and intervention. As the demand for precision in neurological monitoring increases, the use of intraparenchymal monitors is expected to rise, driven by their effectiveness and reliability in clinical practice.

Subarachnoid Bolus Catheters:

Subarachnoid bolus catheters are utilized for both the administration of therapeutic agents and the monitoring of intracranial pressure. These devices are particularly useful in managing patients with various neurological conditions, allowing for effective communication between clinicians and the monitoring system. While their primary function is not solely ICP monitoring, their ability to provide pressure readings enhances their utility in clinical practice. The convenience of administering treatments directly while monitoring ICP with the same device is likely to support the growth of this segment in the market.

Others:

The "Others" category encompasses various novel mechanical systems designed for intracranial pressure monitoring, including advanced systems that integrate multiple monitoring capabilities. Innovations in this field are focused on enhancing patient safety and comfort, particularly by reducing the invasiveness of devices while maintaining accuracy. As research continues to yield new approaches for ICP monitoring, the demand for these advanced mechanical systems is expected to grow, contributing to the overall progress of the intracranial pressure monitoring devices market.

By Region

The intracranial pressure monitoring devices market is geographically segmented into several regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America currently dominates the market with a substantial share, primarily driven by the presence of advanced healthcare infrastructure, a high prevalence of neurological disorders, and a strong emphasis on research and development in medical technology. The North American region is expected to witness a CAGR of approximately 6.5% over the forecast period, reflecting the continuous adoption of innovative monitoring solutions in healthcare facilities. The region's well-established healthcare systems and increasing awareness of patient safety are further propelling market growth.

Europe is another key region for the intracranial pressure monitoring devices market, characterized by a growing aging population and rising incidences of conditions such as strokes and traumatic brain injuries. The European market is expected to grow steadily, benefiting from advancements in medical technology and increasing investments in healthcare infrastructure. The Asia Pacific region is emerging as a significant player in the market, driven by rapid urbanization, increasing healthcare expenditures, and a growing awareness of neurological health. Countries like China and India are projected to experience robust growth as the demand for advanced medical technologies expands. Overall, the diverse regional dynamics are shaping the landscape of the intracranial pressure monitoring devices market, with each region contributing to global growth in distinct ways.

Opportunities

The intracranial pressure monitoring devices market presents numerous opportunities for stakeholders, especially in light of the growing prevalence of neurological conditions and advancements in medical technology. As healthcare systems across the globe continue to evolve, there is a pressing need for more accurate and efficient monitoring solutions. This demand opens avenues for manufacturers to innovate and develop next-generation devices that not only provide real-time data but also enhance patient comfort and safety. Collaborations between technology firms and healthcare providers can lead to the creation of integrated solutions that combine ICP monitoring with other critical parameters, thereby enhancing the overall utility of these devices. Moreover, the expansion of telemedicine and remote monitoring technologies presents a unique opportunity for ICP monitoring, allowing healthcare professionals to access patient data from afar and make informed decisions, thus improving patient outcomes.

Furthermore, the increasing focus on preventive care is creating opportunities for the intracranial pressure monitoring devices market. As healthcare providers prioritize early detection and intervention, there is a growing emphasis on utilizing monitoring devices in outpatient settings and rehabilitation centers. This trend is encouraging manufacturers to adapt their strategies and develop solutions suitable for a wider range of environments. With the rise of home healthcare, the demand for portable and user-friendly ICP monitoring devices is likely to increase, enabling patients to manage their conditions more effectively in the comfort of their homes. Overall, the market is poised for growth, driven by evolving healthcare paradigms and the need for innovative monitoring solutions.

Threats

The intracranial pressure monitoring devices market faces several threats that could impact its growth trajectory. One of the primary concerns is the stringent regulatory environment governing medical devices, which can pose significant challenges for manufacturers seeking to bring new products to market. Compliance with regulatory standards requires substantial time and financial investment, which may deter smaller companies from entering the market. Additionally, the presence of established players with significant market share can create barriers to entry for new entrants, limiting competition and innovation. Moreover, the potential for product recalls due to safety concerns or regulatory non-compliance can damage brand reputation and lead to financial losses.

Another threat to the market stems from the rapid advancements in alternative technologies that may outpace traditional ICP monitoring methods. As non-invasive techniques continue to emerge and gain acceptance among healthcare providers, there is a risk that invasive monitoring methods may become less favored. This shift in preference could lead to declining demand for certain types of monitoring devices, particularly those associated with higher complication rates. Additionally, economic fluctuations and budget constraints in healthcare systems can impact purchasing decisions, potentially hindering the growth of the market. Manufacturers must remain vigilant and adaptable to navigate these threats while continuing to meet the evolving needs of healthcare providers and patients.

Competitor Outlook

• Medtronic PLC
• Codman & Shurtleff, Inc. (Johnson & Johnson)
• Integra LifeSciences Corporation
• Raumedic AG
• NeuroWave Systems, Inc.
• Natus Medical Incorporated
• Schneider Electric
• Orbis Health Solutions
• STMicroelectronics
• Spacelabs Healthcare
• Siemens Healthineers
• ARGOS Technologies
• Rudolph Technologies
• BrainScope Company, Inc.
• NeuroTrauma LLC

The competitive landscape of the intracranial pressure monitoring devices market is characterized by the presence of several key players and a continuous influx of new entrants aiming to capture market share. Established companies such as Medtronic and Codman & Shurtleff have a strong foothold due to their extensive product offerings and established distribution networks. These companies invest heavily in research and development to innovate their existing product lines and introduce new technologies that enhance monitoring capabilities. Furthermore, strategic partnerships and collaborations are common in this market, allowing companies to leverage each other's strengths in technology and distribution to improve their market position.

Moreover, the market is witnessing an increasing trend toward consolidation, with companies acquiring smaller firms to expand their product portfolios and enter new geographical regions. For instance, Natus Medical's acquisition of a neurodiagnostic company has enhanced its offerings in the neurological monitoring space, illustrating the drive toward growth through strategic acquisitions. Additionally, companies are focusing on enhancing customer service and support, recognizing that end-users value comprehensive solutions that go beyond the device itself. By providing robust training, technical assistance, and ongoing maintenance, manufacturers can foster long-term relationships with healthcare providers and differentiate themselves in a competitive market.

Key players in the intracranial pressure monitoring devices market, such as Integra LifeSciences and Raumedic, are committed to technological advancements, emphasizing the importance of precision and patient safety. For example, Integra LifeSciences has been at the forefront of developing advanced monitoring systems that incorporate data analytics and artificial intelligence to enhance clinical decision-making. These innovations not only improve the accuracy of ICP monitoring but also provide actionable insights to healthcare professionals. Similarly, companies like NeuroWave Systems are focusing on creating non-invasive monitoring solutions that cater to the growing demand for safer and more comfortable patient experiences. As the market evolves, it is anticipated that competition will intensify, necessitating ongoing innovation and adaptation to meet the changing demands of healthcare providers and patients.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Raumedic AG
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Medtronic PLC
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 NeuroTrauma LLC
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 ARGOS Technologies
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 STMicroelectronics
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Schneider Electric
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Rudolph Technologies
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Siemens Healthineers
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Spacelabs Healthcare
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Orbis Health Solutions
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 NeuroWave Systems, Inc.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 BrainScope Company, Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Natus Medical Incorporated
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Integra LifeSciences Corporation
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Codman & Shurtleff, Inc. (Johnson & Johnson)
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Intracranial Pressure Monitoring Devices Market, By user
    • 6.1.1 Hospitals
    • 6.1.2 Clinics
    • 6.1.3 Ambulatory Surgical Centers
    • 6.1.4 Others
  • 6.2 Intracranial Pressure Monitoring Devices Market, By Technology
    • 6.2.1 Micro-Electro-Mechanical Systems (MEMS)
    • 6.2.2 Fiber Optic Sensors
    • 6.2.3 Strain Gauge Sensors
    • 6.2.4 Others
  • 6.3 Intracranial Pressure Monitoring Devices Market, By Application
    • 6.3.1 Traumatic Brain Injury
    • 6.3.2 Stroke
    • 6.3.3 Intracerebral Hemorrhage
    • 6.3.4 Meningitis
    • 6.3.5 Others
  • 6.4 Intracranial Pressure Monitoring Devices Market, By Product Type
    • 6.4.1 Invasive ICP Monitoring Devices
    • 6.4.2 Non-Invasive ICP Monitoring Devices

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Intracranial Pressure Monitoring Devices Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Intracranial Pressure Monitoring Devices market is categorized based on

By Product Type

• Invasive ICP Monitoring Devices
• Non-Invasive ICP Monitoring Devices

By Application

• Traumatic Brain Injury
• Stroke
• Intracerebral Hemorrhage
• Meningitis
• Others

By user

• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Others

By Technology

• Micro-Electro-Mechanical Systems (MEMS)
• Fiber Optic Sensors
• Strain Gauge Sensors
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Medtronic PLC
• Codman & Shurtleff, Inc. (Johnson & Johnson)
• Integra LifeSciences Corporation
• Raumedic AG
• NeuroWave Systems, Inc.
• Natus Medical Incorporated
• Schneider Electric
• Orbis Health Solutions
• STMicroelectronics
• Spacelabs Healthcare
• Siemens Healthineers
• ARGOS Technologies
• Rudolph Technologies
• BrainScope Company, Inc.
• NeuroTrauma LLC